RUNX2 Antibody Blocking peptide

Runt-related transcription factor 2, Acute myeloid leukemia 3 protein, Core-binding factor subunit alpha-1, CBF-alpha-1, Oncogene AML-3, Osteoblast-specific transcription factor 2, OSF-2, Polyomavirus enhancer-binding protein 2 alpha A subunit, PEA2-alpha A, PEBP2-alpha A, SL3-3 enhancer factor 1 alpha A subunit, SL3/AKV core-binding factor alpha A subunit, RUNX2, AML3, CBFA1, OSF2, PEBP2A

The synthetic peptide sequence used to generate the antibody orb1928937 was selected from the N-term region of human Runx2. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.